IL118092D0 - Antibacterial compounds their preparation and pharmaceutical compositions containing them - Google Patents

Antibacterial compounds their preparation and pharmaceutical compositions containing them

Info

Publication number
IL118092D0
IL118092D0 IL11809296A IL11809296A IL118092D0 IL 118092 D0 IL118092 D0 IL 118092D0 IL 11809296 A IL11809296 A IL 11809296A IL 11809296 A IL11809296 A IL 11809296A IL 118092 D0 IL118092 D0 IL 118092D0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
antibacterial compounds
antibacterial
compounds
pharmaceutical
Prior art date
Application number
IL11809296A
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9508955.3A priority Critical patent/GB9508955D0/en
Priority to GBGB9508956.1A priority patent/GB9508956D0/en
Priority to GBGB9508957.9A priority patent/GB9508957D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL118092D0 publication Critical patent/IL118092D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4 and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4 and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4 and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D477/02Preparation
    • C07D477/06Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08Modification of a carboxyl group directly attached in position 2, e.g. esterification
IL11809296A 1995-05-03 1996-05-01 Antibacterial compounds their preparation and pharmaceutical compositions containing them IL118092D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9508955.3A GB9508955D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508956.1A GB9508956D0 (en) 1995-05-03 1995-05-03 Novel compounds
GBGB9508957.9A GB9508957D0 (en) 1995-05-03 1995-05-03 Novel compounds

Publications (1)

Publication Number Publication Date
IL118092D0 true IL118092D0 (en) 1996-09-12

Family

ID=27267696

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11809296A IL118092D0 (en) 1995-05-03 1996-05-01 Antibacterial compounds their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0823910A1 (en)
JP (1) JPH11504910A (en)
KR (1) KR19990008355A (en)
CN (1) CN1185783A (en)
AR (1) AR005416A1 (en)
AU (1) AU5813996A (en)
BG (1) BG102014A (en)
BR (1) BR9608313A (en)
CA (1) CA2217990A1 (en)
CZ (1) CZ347597A3 (en)
EA (1) EA199700293A1 (en)
HU (1) HU9801066A3 (en)
IL (1) IL118092D0 (en)
MA (1) MA23853A1 (en)
MX (1) MX9708421A (en)
NO (1) NO974994L (en)
OA (1) OA10632A (en)
PE (1) PE50697A1 (en)
PL (1) PL323141A1 (en)
SK (1) SK146497A3 (en)
TR (1) TR199701286T1 (en)
WO (1) WO1996034868A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902659A1 (en) 2006-06-23 2007-12-28 Pierre Fabre Medicament Sa Dha ester and its use in the treatment and prevention of cardiovascular diseases
WO2013157583A1 (en) * 2012-04-18 2013-10-24 大日本住友製薬株式会社 Novel carbapenem compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
CA1212105A (en) * 1980-04-30 1986-09-30 Shoji Ikeda Ampicillin esters and production thereof
WO1995005380A1 (en) * 1993-08-18 1995-02-23 Sankyo Company, Limited Crystalline carbapenem derivatives
SK53696A3 (en) * 1993-10-29 1996-10-01 Smithkline Beecham Plc Carbapenem derivatives, their preparation, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
CZ347597A3 (en) 1998-08-12
KR19990008355A (en) 1999-01-25
BG102014A (en) 1998-11-30
CN1185783A (en) 1998-06-24
AU5813996A (en) 1996-11-21
WO1996034868A1 (en) 1996-11-07
NO974994D0 (en) 1997-10-30
OA10632A (en) 2002-09-16
AR005416A1 (en) 1999-06-23
SK146497A3 (en) 1998-05-06
PE50697A1 (en) 1997-12-18
BR9608313A (en) 1999-01-26
HU9801066A3 (en) 1999-01-28
TR199701286T1 (en) 1998-02-21
EP0823910A1 (en) 1998-02-18
EA199700293A1 (en) 1998-06-25
PL323141A1 (en) 1998-03-16
CA2217990A1 (en) 1996-11-07
HU9801066A2 (en) 1998-08-28
NO974994L (en) 1997-10-30
MA23853A1 (en) 1996-12-31
JPH11504910A (en) 1999-05-11
MX9708421A (en) 1998-02-28

Similar Documents

Publication Publication Date Title
IL104740A (en) Hypolipidaemic benzothiazepine compounds their preparation and pharmaceutical compositions containing them
IL116385A (en) Sulphonamides their manufacture and pharmaceutical compositions containing them
IL109496D0 (en) Substituted pyrrolidin-3-yl-alkyl-piperidines and pharmaceutical compositions containing them
IL112292D0 (en) Pharmaceutical compositions containing 1-aminoindan and derivatives thereof
HK1002384A1 (en) Pharmaceutical compositions containing irbesartan
CZ99396A3 (en) Macrolide compounds and pharmaceutical composition containing thereof
ZA9307459B (en) Pharmaceutical composition
ZA9300234B (en) Flavour-masked pharmaceutical compositions
NZ272623A (en) 1-phenyl-3-dimethylaminopropane compounds, preparation and pharmaceutical compositions thereof
IL112248D0 (en) Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
ZA9308825B (en) Pharmaceutical compositions
IL107568A (en) Substituted amidino compounds, their preparation and pharmaceutical compositions containing them
IL110978A (en) 17beta-anilide-4-aza-5alpha-androst-1-en-3-one derivative its preparation and pharmaceutical composition containing it
IL104559D0 (en) N-sulfonyl-2-oxoindole derivatives,their preparation and pharmaceutical compositions containing them
DE69616323D1 (en) Aromatic compounds and pharmaceutical compositions containing them
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
GB9212511D0 (en) Pharmaceutical compositions
IL117636A (en) Taxoids, their preparation and pharmaceutical compositions containing them
IL108306A (en) DE-O-(alpha-oleandrosyl)-5-demethoxy-avermectin-5-oximes their preparation and pharmaceutical antiparasitic compounds containing them
IL105220D0 (en) Cyclohexanylidene compounds and pharmaceutical compositions containing them
IL108486D0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL103688A (en) Substituted biphenylpyridones their preparation and pharmaceutical compositions containing them
IL104006A (en) Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them
IL116770A (en) 2,8-disubstituted quinazolinones their preparation and pharmaceutical compositions containing them
IL113651D0 (en) Pharmaceutical compositions containing alendronate and their use